Atlas Trials

5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

Clinical trial NCT01652781 · UNKNOWN

Trial details

NCT number
NCT01652781
Sponsor
Seoul St. Mary's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2012-03-01
Primary completion
2016-06-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.